KCNA5 and pulmonary arterial hypertension: Additive effects between BMPR2 and KCNA5 mutations may underlie the earlier age of onset and higher disease severity in digenic patients, suggesting that mutational load and the presence of ‘second hits’ is important in PAH progression [28].